ClinicalTrials.gov record
Completed Phase 3 Interventional

A Randomized Phase III Clinical Trial of Daunoxome Versus Combination Chemotherapy With Adriamycin/Bleomycin/Vincristine (ABV) in the Treatment of HIV-Associated Kaposi's Sarcoma.

ClinicalTrials.gov ID: NCT00002093

Public ClinicalTrials.gov record NCT00002093. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 15, 2026, 2:03 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT00002093
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Nexstar Pharmaceuticals
Industry
Enrollment
Not listed

Conditions and interventions

Interventions

  • Bleomycin sulfate Drug
  • Daunorubicin (liposomal) Drug
  • Doxorubicin hydrochloride Drug
  • Vincristine sulfate Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
Jun 23, 2005

United States locations

U.S. sites
13
U.S. states
10
U.S. cities
12
Facility City State ZIP Site status
Univ of Arizona / Arizona Cancer Ctr Tucson Arizona 85724
Kenneth Norris Jr Cancer Hosp Los Angeles California 90033
Desert Hosp Comprehensive Cancer Ctr Palm Springs California 92262
Saint Francis Mem Hosp San Francisco California 94109
Davies Med Ctr San Francisco California 94114
Denver Gen Hosp Denver Colorado 802044507
George Washington Univ Med Ctr Washington D.C. District of Columbia 20037
Univ of Miami Dept of Medicine Miami Florida 33136
Northwestern Univ Med School Chicago Illinois 60611
New England Deaconess Hosp Boston Massachusetts 02215
New York Univ Med Ctr New York New York 10016
Kaiser Permanente Med Ctr Portland Oregon 97227
Dr Edward Stool Houston Texas 77004

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00002093, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 23, 2005 · Synced May 15, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00002093 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →